Pharmacokinetic Bioequivalence Studies of a New Etoricoxib Tablet Formulation Developed Using Proprietary MiST Technology — Risk Assessment and Mitigation Using GastroPlus Software
Generics and Biosimilars Initiative Journal(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined